/RGBP
RGBP Stock - Regen BioPharma, Inc.
Healthcare|BiotechnologyOTC
$0.01+3.63%
+$0.00 (+3.63%) • Dec 19
35
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.SELL
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RGBP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.01
STOP LOSS$0.01
RISK/REWARD1:NaN
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.08
52W High$0.12
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $236,560 | $236,560 | $235,517 | $171,194 | $110,000 |
| Gross Profit | $236,560 | $236,560 | $185,517 | $146,194 | $110,000 |
| Gross Margin | 100.0% | 100.0% | 78.8% | 85.4% | 100.0% |
| Operating Income | $-417,000 | $-687,000 | $-340,000 | $-201,000 | $-209,000 |
| Net Income | $-668,000 | $1.02M | $2.23M | $-6,765,000 | $2.73M |
| Net Margin | -282.4% | 432.9% | 945.6% | -3951.7% | 2483.6% |
| EPS | $-0.16 | $0.14 | $0.36 | $-1.69 | $1.90 |
Company Overview
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RGBPBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q2 25
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | — | — | — | — |
Q4 2025 | Nov 27, 2025 | — | — | — | — |
Q3 2025 | Aug 11, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 28, 2025 | — | $-0.00 | — | — |
Q2 2025 | May 16, 2025 | — | $-0.06 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.06 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.03 | — | — |
Q2 2024 | Apr 24, 2024 | — | $-0.03 | — | — |
Q1 2024 | Mar 7, 2024 | — | $-0.10 | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.08 | — | — |
Q3 2023 | Jul 25, 2023 | — | $-0.03 | — | — |
Q2 2023 | Apr 18, 2023 | — | $-0.02 | — | — |
Q1 2023 | Jan 19, 2023 | — | $0.43 | — | — |
Q4 2022 | Nov 15, 2022 | — | $0.05 | — | — |
Q3 2022 | Jul 22, 2022 | — | $19.11 | — | — |
Q2 2022 | Apr 21, 2022 | — | $-22.04 | — | — |
Q1 2022 | Jan 20, 2022 | — | $0.80 | — | — |
Q4 2021 | Dec 22, 2021 | — | $-1.04 | — | — |
Q3 2021 | Aug 26, 2021 | — | $-3.14 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RGBP
What is RGBP's current stock price?
Regen BioPharma, Inc. (RGBP) is currently trading at $0.01 per share. The stock has moved +3.63% today.
What is the analyst price target for RGBP?
No analyst price targets are currently available for this stock.
What sector is Regen BioPharma, Inc. in?
Regen BioPharma, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is RGBP's market cap?
Regen BioPharma, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RGBP pay dividends?
No, Regen BioPharma, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCBDG
THC Farmaceuticals, Inc.
$0.01
Mkt Cap: $0.0B
CHNXF
ChitogenX Inc.
$0.01
Mkt Cap: $0.0B
DPAT
Dental Patient Care America, Inc.
$0.01
Mkt Cap: $0.0B
IPIX
Innovation Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
LVTTF
Levitee Labs Inc.
$0.00
Mkt Cap: $0.0B
NBIO
Nascent Biotech, Inc.
$0.00
Mkt Cap: $0.0B
RASP
Actavia Life Sciences, Inc.
$0.00
Mkt Cap: $0.0B
RSPI
RespireRx Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
VIRX
Viracta Therapeutics, Inc.
$0.01
Mkt Cap: $0.0B
WSNAF
Wesana Health Holdings Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to RGBP for comparison